Current status of pharmacological thrombolytic therapy and mechanical thrombectomy for the treatment of acute deep venous thrombosis

Thomas J. Kiernan, Beatriz Cepeda, Gareth D. Kiernan, Bryan P. Yan

Research output: Contribution to journalArticlepeer-review

Abstract

Deep venous thrombosis (DVT) is a highly prevalent clinical problem associated with significant mortality and morbidity. In the United States alone, it is estimated that DVT affects approximately 50 per 100,000 people per year. This results in >600,000 inpatient and outpatient treatments per year and accounts for approximately 100,000 deaths from thromboembolic complications. Post-thrombotic syndrome (PTS) is associated with serious long-term physical, social and economic sequelae for patients. In this article, we attempt to perform a contemporary review of the literature pertaining to the use of thrombolytic therapy and endovascular thrombectomy in the treatment of acute DVT.

Original languageEnglish
Pages (from-to)12-18
Number of pages7
JournalCardiovascular and Hematological Agents in Medicinal Chemistry
Volume7
Issue number1
DOIs
Publication statusPublished - 2009
Externally publishedYes

Fingerprint

Dive into the research topics of 'Current status of pharmacological thrombolytic therapy and mechanical thrombectomy for the treatment of acute deep venous thrombosis'. Together they form a unique fingerprint.

Cite this